Financhill
Back

EyePoint Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
56

EYPT
EyePoint Pharmaceuticals

Last Price:
12.05
Seasonality Move:
19.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

EyePoint Pharmaceuticals Price Quote

$12.05
+0.44 (+3.79%)
(Updated: November 6, 2024 at 5:55 PM ET)

EyePoint Pharmaceuticals Key Stats

Buy
56
EyePoint Pharmaceuticals (EYPT) is a Buy

Day range:
$11.06 - $11.71
52-week range:
$5.86 - $30.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
10.75
P/B ratio:
2.72%

Volume:
416.2K
Avg. volume:
878.4K
1-year change:
49.81%
Market cap:
$621.3M
Revenue:
$46M
EPS:
$-1.78

How Much Does EyePoint Pharmaceuticals Make?

Is EyePoint Pharmaceuticals Growing As A Company?

EyePoint Pharmaceuticals Stock Price Performance

What Is EyePoint Pharmaceuticals 52-Week High & Low?

EyePoint Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy EyePoint Pharmaceuticals?

Is EyePoint Pharmaceuticals Cash Flow Positive?

  • What Is EYPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$89.7M
  • What Is EyePoint Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $229.3M
  • What Is EyePoint Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$188.5M

EyePoint Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    EYPT return on invested capital is -50.45%
  • What Is EyePoint Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -32.29%
  • What Is EYPT Return On Equity?
    ROE is a measure of profitability and is -50.45%

EyePoint Pharmaceuticals Earnings Date & Stock Price

EyePoint Pharmaceuticals Competitors

EyePoint Pharmaceuticals Dividend Yield

EyePoint Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -14.45%
Revenue: 4.09% -10.89%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 36.18
Upside from Last Price: 211.64%

Major Shareholders

  • How many EYPT shares are owned by institutional investors?
    92.7M EYPT shares are owned by institutional investors
  • How many EYPT shares are owned by insiders?
    1.4M EYPT shares are owned by insiders